The clinical success of fulvestrant also led to efforts to discover and develop a parallel drug class of selective androgen receptor degraders (SARDs).ZB716, or fulvestrant-3-boronic acid, is an oral prodrug of fulvestrant which is under development. References
External links
"Fulvestrant". Drug Information Portal. U.S. National Library of Medicine.
See also
List of cutaneous conditions
List of radiographic findings associated with cutaneous conditions

References


== External links ==